Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy

• References

• 1 Schroecksnadel K, Grammer TB, Boehm BO. et al. Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers. Thromb Haemost 2010; 103: 926-935.
• 2 Di Minno MND, Tremoli E, Di Minno G. Homo-cysteine and arterial thrombosis: challenge and opportunity. Thromb Haemost 2010; 103: 942-961.
• 3 Loeffler C, Straub A, Bassler N. et al. Evaluation of platelet activation in patients supported by the Jarvik 2000* high-rotational speed impeller ventricular assist device. J Thorac Cardiovasc Surg 2009; 137: 736-741.
• 4 Heilmann C, Geisen U, Nakamura L. et al. Acquired von Willebrand syndrome in patients wiht ventricular assist devide or total artificial heart. Thromb Haemost 2010; 103: 962-967.
• 5 Lankeit M, Konstantinides S. Thrombolysis for pulmonary embolism: Past, present and future. Thromb Haemost 2010; 103: 877-883.
• 6 Burggraf D, Vosko MR, Schubert M. Different therapy options protecting microvasculature after experimental cerebral ischemia and reperfusion. Thromb Haemost 2010; 103: 891-900.
• 7 Harmsze AM, Robijins K, von Werkum JW. et al. The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers in associated with clopidogrel poor-response. Thromb Haemost 2010; 103: 920-925.
• 8 Van Walderveen MC, Berry LR, Atkinson HM. et al. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va. Thromb Haemost 2010; 103: 910-919.